Vericel Historical Income Statement

VCEL Stock

USD 58.14 0.38 0.66%

Historical analysis of Vericel Corp income statement accounts such as Depreciation And Amortization of 4.9 M, Interest Expense of 630 K, Total Revenue of 207.4 M or Gross Profit of 142.4 M can show how well Vericel Corp Ord performed in making a profits. Evaluating Vericel Corp income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Vericel Corp's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Vericel Corp Ord latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Vericel Corp Ord is a good buy for the upcoming year.

Net Income Gross Profit

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vericel Corp Ord. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

About Vericel Income Statement Analysis

Vericel Corp Ord Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Vericel Corp shareholders. The income statement also shows Vericel investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Vericel Corp Income Statement Chart

At this time, Vericel Corp's EBITDA is quite stable compared to the past year. Cost Of Revenue is expected to rise to about 65 M this year, although the value of EBIT will most likely fall to (1.9 M).

Total Revenue Other Operating Expenses Total Operating Expenses

Total Revenue

Total revenue comprises all receipts Vericel Corp Ord generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Vericel Corp Ord. It is also known as Vericel Corp overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Most accounts from Vericel Corp's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Vericel Corp Ord current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vericel Corp Ord. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	113.9M	126.8M	142.0M	149.1M
Cost Of Revenue	50.2M	54.6M	61.9M	65.0M

Total Operating Expenses Cost Of Revenue

Vericel Corp income statement Correlations

	Depreciation And Amortization	Interest Expense	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Selling General Administrative	Research Development	Net Income From Continuing Ops	Non Operating Income Net Other	Non Recurring	Interest Income	Net Interest Income	Reconciled Depreciation	Tax Provision
Depreciation And Amortization		-0.12	0.75	0.76	0.75	0.46	0.38	0.57	0.71	0.76	0.53	0.0	0.5	0.25	0.79	-0.14	0.53	-0.21	-0.3	0.39	0.51	0.81	0.34
Interest Expense	-0.12		0.29	0.27	0.26	0.38	0.4	0.33	0.33	0.23	0.2	-0.48	0.18	0.45	0.26	-0.39	0.19	-0.64	-0.22	0.25	-0.02	0.05	0.18
Total Revenue	0.75	0.29		1.0	0.99	0.68	0.69	0.78	0.98	0.98	0.7	-0.17	0.68	0.51	0.99	-0.02	0.64	-0.54	-0.62	0.77	0.79	0.81	0.38
Gross Profit	0.76	0.27	1.0		0.99	0.66	0.67	0.77	0.96	0.99	0.7	-0.12	0.69	0.47	0.99	0.01	0.64	-0.51	-0.63	0.78	0.81	0.82	0.37
Other Operating Expenses	0.75	0.26	0.99	0.99		0.6	0.61	0.72	0.97	0.99	0.63	-0.11	0.61	0.47	0.99	0.05	0.57	-0.51	-0.64	0.78	0.81	0.83	0.41
Operating Income	0.46	0.38	0.68	0.66	0.6		0.96	0.96	0.7	0.54	0.94	-0.49	0.94	0.62	0.62	-0.45	0.88	-0.51	-0.32	0.43	0.42	0.38	0.0
Ebit	0.38	0.4	0.69	0.67	0.61	0.96		0.98	0.71	0.55	0.9	-0.5	0.9	0.72	0.62	-0.41	0.81	-0.55	-0.43	0.53	0.5	0.38	0.05
Ebitda	0.57	0.33	0.78	0.77	0.72	0.96	0.98		0.8	0.66	0.92	-0.45	0.92	0.7	0.73	-0.39	0.84	-0.54	-0.45	0.56	0.56	0.52	0.13
Cost Of Revenue	0.71	0.33	0.98	0.96	0.97	0.7	0.71	0.8		0.94	0.68	-0.3	0.66	0.61	0.96	-0.09	0.61	-0.6	-0.59	0.71	0.73	0.77	0.37
Total Operating Expenses	0.76	0.23	0.98	0.99	0.99	0.54	0.55	0.66	0.94		0.59	-0.02	0.58	0.39	0.99	0.11	0.54	-0.46	-0.65	0.79	0.83	0.85	0.42
Income Before Tax	0.53	0.2	0.7	0.7	0.63	0.94	0.9	0.92	0.68	0.59		-0.17	1.0	0.39	0.66	-0.36	0.91	-0.29	-0.46	0.57	0.59	0.47	0.03
Total Other Income Expense Net	0.0	-0.48	-0.17	-0.12	-0.11	-0.49	-0.5	-0.45	-0.3	-0.02	-0.17		-0.19	-0.82	-0.1	0.42	-0.27	0.72	-0.27	0.24	0.29	0.12	0.11
Net Income	0.5	0.18	0.68	0.69	0.61	0.94	0.9	0.92	0.66	0.58	1.0	-0.19		0.38	0.64	-0.33	0.92	-0.29	-0.43	0.55	0.58	0.44	0.0
Income Tax Expense	0.25	0.45	0.51	0.47	0.47	0.62	0.72	0.7	0.61	0.39	0.39	-0.82	0.38		0.45	-0.34	0.35	-0.75	-0.18	0.24	0.19	0.27	0.14
Selling General Administrative	0.79	0.26	0.99	0.99	0.99	0.62	0.62	0.73	0.96	0.99	0.66	-0.1	0.64	0.45		-0.01	0.59	-0.47	-0.63	0.76	0.79	0.86	0.41
Research Development	-0.14	-0.39	-0.02	0.01	0.05	-0.45	-0.41	-0.39	-0.09	0.11	-0.36	0.42	-0.33	-0.34	-0.01		-0.31	0.2	0.07	0.15	0.25	0.06	0.14
Net Income From Continuing Ops	0.53	0.19	0.64	0.64	0.57	0.88	0.81	0.84	0.61	0.54	0.91	-0.27	0.92	0.35	0.59	-0.31		-0.47	-0.2	0.33	0.38	0.34	-0.09
Non Operating Income Net Other	-0.21	-0.64	-0.54	-0.51	-0.51	-0.51	-0.55	-0.54	-0.6	-0.46	-0.29	0.72	-0.29	-0.75	-0.47	0.2	-0.47		0.09	-0.16	-0.07	-0.17	-0.02
Non Recurring	-0.3	-0.22	-0.62	-0.63	-0.64	-0.32	-0.43	-0.45	-0.59	-0.65	-0.46	-0.27	-0.43	-0.18	-0.63	0.07	-0.2	0.09		-0.89	-0.83	-0.5	-0.3
Interest Income	0.39	0.25	0.77	0.78	0.78	0.43	0.53	0.56	0.71	0.79	0.57	0.24	0.55	0.24	0.76	0.15	0.33	-0.16	-0.89		0.95	0.69	0.49
Net Interest Income	0.51	-0.02	0.79	0.81	0.81	0.42	0.5	0.56	0.73	0.83	0.59	0.29	0.58	0.19	0.79	0.25	0.38	-0.07	-0.83	0.95		0.75	0.44
Reconciled Depreciation	0.81	0.05	0.81	0.82	0.83	0.38	0.38	0.52	0.77	0.85	0.47	0.12	0.44	0.27	0.86	0.06	0.34	-0.17	-0.5	0.69	0.75		0.59
Tax Provision	0.34	0.18	0.38	0.37	0.41	0.0	0.05	0.13	0.37	0.42	0.03	0.11	0.0	0.14	0.41	0.14	-0.09	-0.02	-0.3	0.49	0.44	0.59

Click cells to compare fundamentals

Vericel Corp Account Relationship Matchups

Vericel Corp income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	171.9K	6.8M	7.4M	8.2M	4.6M	4.9M
Total Revenue	117.9M	124.2M	156.2M	164.4M	197.5M	207.4M
Gross Profit	80.3M	84.2M	106.0M	109.8M	135.6M	142.4M
Other Operating Expenses	129.1M	121.8M	164.0M	181.4M	204.0M	214.2M
Operating Income	(11.3M)	667K	(7.9M)	(17.1M)	(6.5M)	(6.8M)
Ebit	(9.8M)	3.1M	(12M)	(19.8M)	(1.8M)	(1.9M)
Ebitda	(9.7M)	9.9M	(4.6M)	(11.6M)	2.9M	3.0M
Cost Of Revenue	37.6M	40.0M	50.2M	54.6M	61.9M	65.0M
Total Operating Expenses	91.5M	81.9M	113.9M	126.8M	142.0M	149.1M
Income Before Tax	(9.7M)	3.0M	(7.6M)	(16.0M)	(2.4M)	(2.5M)
Total Other Income Expense Net	1.6M	672K	272K	1.1M	4.1M	4.3M
Net Income	(7.9M)	2.9M	(7.5M)	(16.7M)	(3.2M)	(3.3M)
Income Tax Expense	(1.8M)	180K	(111K)	721K	814K	854.7K
Selling General Administrative	61.1M	68.8M	97.6M	106.9M	117.0M	122.9M
Research Development	30.4M	13.0M	16.3M	19.9M	21.0M	15.5M
Net Income From Continuing Ops	(9.7M)	2.9M	(7.5M)	(16.7M)	(10.3M)	(10.8M)
Non Operating Income Net Other	1.6M	685K	276K	1.4M	1.3M	1.4M
Net Income Applicable To Common Shares	(9.7M)	2.9M	(7.5M)	(16.7M)	(19.2M)	(20.2M)
Interest Income	1.6M	691K	224K	1.3M	4.0M	4.2M
Net Interest Income	1.6M	685K	220K	975K	3.3M	3.5M
Reconciled Depreciation	1.7M	2.4M	3.0M	4.0M	4.5M	2.9M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Vericel Corp Ord is a strong investment it is important to analyze Vericel Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vericel Corp's future performance. For an informed investment choice regarding Vericel Stock, refer to the following important reports:

How To Invest In Vericel

Details

Is Vericel Stock a good investment?

Details

What is Vericel Corp's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vericel Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

1.045

Earnings Share

0.08

Revenue Per Share

4.685

Quarterly Revenue Growth

0.27

Return On Assets

(0)

The market value of Vericel Corp Ord is measured differently than its book value, which is the value of Vericel that is recorded on the company's balance sheet. Investors also form their own opinion of Vericel Corp's value that differs from its market value or its book value, called intrinsic value, which is Vericel Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vericel Corp's market value can be influenced by many factors that don't directly affect Vericel Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vericel Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Vericel Historical Income Statement

About Vericel Income Statement Analysis

Vericel Corp Income Statement Chart

Total Revenue

Other Operating Expenses

Total Operating Expenses

Vericel Corp income statement Correlations

Vericel Corp Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Vericel Corp income statement Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Gross Profit	+ 1.0	Total Revenue
Net Income	+ 1.0	Income Before Tax
Other Operating Expenses	+ 0.99	Total Revenue
Selling General Administrative	+ 0.99	Total Revenue
Other Operating Expenses	+ 0.99	Gross Profit
Total Operating Expenses	+ 0.99	Gross Profit

Interest Income	- 0.89	Non Recurring
Net Interest Income	- 0.83	Non Recurring
Income Tax Expense	- 0.82	Total Other Income Expense Net
Non Operating Income Net Other	- 0.75	Income Tax Expense
Non Recurring	- 0.65	Total Operating Expenses
Non Recurring	- 0.64	Other Operating Expenses